Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK)
HKD 4.46
(0.22%)
HKD 4.46
(0.22%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.53 CNY | -206.0% |
| 2022 | 0.50 CNY | 212.5% |
| 2021 | 0.16 CNY | -78.95% |
| 2020 | 0.76 CNY | -10.59% |
| 2019 | 0.85 CNY | 73.47% |
| 2018 | 0.49 CNY | 206.25% |
| 2017 | 0.16 CNY | -50.0% |
| 2016 | 0.32 CNY | -30.43% |
| 2015 | 0.46 CNY | 76.92% |
| 2014 | 0.26 CNY | 4.0% |
| 2013 | 0.25 CNY | -48.98% |
| 2012 | 0.49 CNY | 0.0% |
| 2011 | 0.49 CNY | -75.0% |
| 2010 | 1.96 CNY | 180.0% |
| 2009 | 0.70 CNY | 25.0% |
| 2008 | 0.56 CNY | 133.33% |
| 2007 | 0.24 CNY | 41.18% |
| 2006 | 0.17 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.11 CNY | 117.46% |
| 2024 Q2 | 0.35 CNY | 218.18% |
| 2023 Q3 | 0.01 CNY | -65.12% |
| 2023 Q2 | 0.04 CNY | -14.57% |
| 2023 Q4 | -0.63 CNY | -4766.67% |
| 2023 Q1 | 0.05 CNY | -11.18% |
| 2023 FY | - CNY | -206.0% |
| 2022 Q2 | 0.19 CNY | 18.75% |
| 2022 Q4 | 0.05 CNY | -46.99% |
| 2022 FY | - CNY | 212.5% |
| 2022 Q1 | 0.16 CNY | 206.67% |
| 2022 Q3 | 0.10 CNY | -49.37% |
| 2021 FY | - CNY | -78.95% |
| 2021 Q1 | 0.10 CNY | -57.48% |
| 2021 Q2 | 0.13 CNY | 32.92% |
| 2021 Q3 | 0.08 CNY | -35.31% |
| 2021 Q4 | -0.15 CNY | -278.36% |
| 2020 Q3 | 0.09 CNY | -64.81% |
| 2020 Q2 | 0.26 CNY | 30.0% |
| 2020 Q1 | 0.20 CNY | -35.48% |
| 2020 FY | - CNY | -10.59% |
| 2020 Q4 | 0.23 CNY | 151.37% |
| 2019 Q1 | 0.41 CNY | 215.38% |
| 2019 Q2 | 0.03 CNY | -92.29% |
| 2019 Q3 | 0.10 CNY | 216.46% |
| 2019 Q4 | 0.31 CNY | 210.0% |
| 2019 FY | - CNY | 73.47% |
| 2018 Q1 | 0.06 CNY | -12.66% |
| 2018 FY | - CNY | 206.25% |
| 2018 Q2 | 0.14 CNY | 153.62% |
| 2018 Q3 | 0.17 CNY | 21.43% |
| 2018 Q4 | 0.13 CNY | -23.53% |
| 2017 Q4 | 0.06 CNY | 0.32% |
| 2017 Q1 | -0.01 CNY | -114.88% |
| 2017 FY | - CNY | -50.0% |
| 2017 Q2 | 0.02 CNY | 261.86% |
| 2017 Q3 | 0.06 CNY | 301.27% |
| 2016 Q4 | 0.07 CNY | 117.33% |
| 2016 Q2 | 0.05 CNY | -67.56% |
| 2016 Q1 | 0.16 CNY | 23.08% |
| 2016 FY | - CNY | -30.43% |
| 2016 Q3 | 0.03 CNY | -42.2% |
| 2015 Q4 | 0.13 CNY | 8.33% |
| 2015 FY | - CNY | 76.92% |
| 2015 Q3 | 0.12 CNY | 72.41% |
| 2015 Q2 | 0.07 CNY | -50.29% |
| 2015 Q1 | 0.14 CNY | 59.82% |
| 2014 Q3 | 0.09 CNY | 183.17% |
| 2014 Q1 | 0.06 CNY | 188.72% |
| 2014 Q4 | 0.09 CNY | 0.11% |
| 2014 FY | - CNY | 4.0% |
| 2014 Q2 | 0.03 CNY | -45.12% |
| 2013 Q4 | 0.02 CNY | -37.7% |
| 2013 FY | - CNY | -48.98% |
| 2013 Q1 | 0.11 CNY | 0.0% |
| 2013 Q2 | 0.08 CNY | -22.82% |
| 2013 Q3 | 0.03 CNY | -63.13% |
| 2012 Q3 | 0.12 CNY | 0.0% |
| 2012 Q2 | 0.12 CNY | -14.29% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q1 | 0.14 CNY | 56.08% |
| 2012 Q4 | 0.11 CNY | -8.33% |
| 2011 Q3 | 0.12 CNY | -25.0% |
| 2011 Q1 | 0.12 CNY | -40.0% |
| 2011 FY | - CNY | -75.0% |
| 2011 Q4 | 0.09 CNY | -25.25% |
| 2011 Q2 | 0.16 CNY | 33.33% |
| 2010 Q1 | 0.22 CNY | -26.67% |
| 2010 FY | - CNY | 180.0% |
| 2010 Q4 | 0.20 CNY | -63.64% |
| 2010 Q3 | 0.55 CNY | 83.33% |
| 2010 Q2 | 0.30 CNY | 36.36% |
| 2009 FY | - CNY | 25.0% |
| 2009 Q1 | 0.11 CNY | 0.0% |
| 2009 Q3 | 0.18 CNY | 50.0% |
| 2009 Q4 | 0.30 CNY | 66.67% |
| 2009 Q2 | 0.12 CNY | 9.09% |
| 2008 FY | - CNY | 133.33% |
| 2007 FY | - CNY | 41.18% |
| 2006 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 0.34 HKD | 255.882% |
| Grand Pharmaceutical Group Limited | 0.54 HKD | 198.148% |
| Extrawell Pharmaceutical Holdings Limited | -0.07 HKD | -677.126% |
| Wai Yuen Tong Medicine Holdings Limited | -0.01 HKD | -3976.923% |
| Qianhai Health Holdings Limited | -0.03 HKD | -1604.18% |
| Lee's Pharmaceutical Holdings Limited | 0.03 HKD | 1966.197% |
| Essex Bio-Technology Limited | 0.49 HKD | 208.163% |
| Tongfang Kontafarma Holdings Limited | -0.01 HKD | -10092.308% |
| PuraPharm Corporation Limited | -0.27 HKD | -96.296% |
| SSY Group Limited | 0.44 HKD | 220.455% |
| JBM (Healthcare) Limited | 0.15 HKD | 453.333% |
| Jacobson Pharma Corporation Limited | 0.12 HKD | 541.667% |
| China Resources Pharmaceutical Group Limited | 0.68 HKD | 177.941% |